To further evaluate the effect of FASN inhibition in CRC, we treated two primary cell lines (Pt 93 and Pt 130) established from PDX tumors [19] with different doses of TVB-3166, TVB-3664 and TVB-3693. The gene discussed is FASN; the disease is colorectal carcinoma.